Gupta Meena, Bajaj B K, Khwaja Geeta
Department of Neurology, GB Pant Hospital, New Delhi-110 002.
J Assoc Physicians India. 2003 Mar;51:257-60.
To report paradoxical response, i.e. recurrence of appearance of fresh symptoms, physical and radiological signs in a patient who had previously shown improvement with appropriate anti-tubercular medicines.
Ten out of 58 patients of CNS tuberculosis, diagnosed on basis of clinical, laboratory and radiological data that initially showed clinical response to therapy only to deteriorate later were included in the study.
Out of ten, three were males and seven were female with age range 13 to 28 years. The duration of time between initiation of therapy and worsening of patient was from one to seven months. Nine out of ten patients developed fresh intracranial tuberculoma while one case otherwise showing improvement developed expansion of tuberculoma and other one of empyema developed tuberculoma while on therapy. All these cases responded to addition of second line therapy or increase in dose of drugs previously prescribed and introduction or increased dose of steroid.
Clinical judgement, regular follow up, guarded reassurance of patient is required to detect parodoxial response in CNS tuberculosis.
报告矛盾反应,即在先前使用适当抗结核药物治疗后病情有所改善的患者中,出现新的症状、体征以及影像学表现复发的情况。
58例中枢神经系统结核患者中,根据临床、实验室及影像学资料确诊,最初对治疗有临床反应但随后病情恶化的10例患者纳入本研究。
10例患者中,3例为男性,7例为女性,年龄范围为13至28岁。从开始治疗到病情恶化的时间为1至7个月。10例患者中有9例出现新的颅内结核瘤,1例原本病情改善的患者结核瘤增大,1例脓胸患者在治疗期间出现结核瘤。所有这些病例对加用二线治疗、增加先前规定药物的剂量以及引入或增加类固醇剂量均有反应。
在中枢神经系统结核中,需要临床判断、定期随访并谨慎地向患者提供保证,以检测矛盾反应。